Literature DB >> 10466586

The placebo effect.

C E Margo1.   

Abstract

Placebos have been traditionally regarded as deceptive therapies and have not been understood in the broader context of social symbols and of interpersonal factors that surround the healing process itself. Although the power of inert substances to heal is well recognized, the placebo effect also influences the outcome of conventional therapies. The role of the placebo in modern medicine is poorly defined because of a lack of a common understanding of what the placebo effect is and because of the negative connotions associated with its use. The response rate to placebo varies by illness. The natural course of disease and patient or physician bias can be misinterpreted as a placebo response. In research, the placebo effect is therapeutic noise to be removed by placebo-controlled trials. Few studies are designed to measure the placebo response rate directly. Placebos are a reminder of how little is known about mind-body interaction. The placebo effect may be one of the most versatile and underused therapeutic tools at the disposal of physicians.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466586     DOI: 10.1016/s0039-6257(99)00060-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  9 in total

1.  Reframing placebo in research and practice.

Authors:  Wayne B Jonas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

2.  The art of medicine.

Authors:  George M Bohigian
Journal:  Mo Med       Date:  2014 Nov-Dec

3.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

4.  Randomized clinical trial of treatments for symptomatic convergence insufficiency in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2008-10

5.  Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.

Authors:  Gregory Katz; Clark L Springs; E Randy Craven; Michela Montecchi-Palmer
Journal:  Clin Ophthalmol       Date:  2010-11-03

Review 6.  [Clinical significance of the placebo effect].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

7.  Effectiveness of placebo therapy for maintaining masking in a clinical trial of vergence/accommodative therapy.

Authors:  Marjean Kulp; G Lynn Mitchell; Eric Borsting; Mitchell Scheiman; Susan Cotter; Michael Rouse; Susanna Tamkins; Brian G Mohney; Andrew Toole; Kathleen Reuter
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

8.  Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy.

Authors:  Vital Paulino Costa; Hamilton Moreira; Mauricio Della Paolera; Maria Rosa Bet de Moraes Silva
Journal:  Clin Ophthalmol       Date:  2012-05-07

9.  Exploring the effect of space and place on response to exercise therapy for knee and hip pain--a protocol for a double-blind randomised controlled clinical trial: the CONEX trial.

Authors:  Louise Fleng Sandal; Jonas Bloch Thorlund; Roger S Ulrich; Paul A Dieppe; Ewa M Roos
Journal:  BMJ Open       Date:  2015-03-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.